University of Tennessee Cancer Institute - Memphis — Memphis, Tennessee

University of Tennessee Cancer Institute - Memphis is a clinical research site located in Memphis, Tennessee, United States 38104.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Tennessee Cancer Institute - Memphis has participated in 12 clinical trials with 1 currently active.

Therapeutic areas: Breast Cancer, Lung Cancer, Recurrent Prostate Cancer.

Sponsors: NSABP Foundation Inc, SWOG Cancer Research Network, ECOG-ACRIN Cancer Research Group.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Tennessee Cancer Institute - Memphis?

University of Tennessee Cancer Institute - Memphis has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Tennessee Cancer Institute - Memphis conducted?

University of Tennessee Cancer Institute - Memphis has 12 clinical trials on record, with 1 currently active. Their work covers Breast Cancer, Lung Cancer, Recurrent Prostate Cancer.

Is University of Tennessee Cancer Institute - Memphis accredited by Crixeo Health?

University of Tennessee Cancer Institute - Memphis has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Tennessee Cancer Institute - Memphis?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.